Literature DB >> 30910721

The frequency of Merkel cell polyomavirus in whole blood from immunocompetent and immunosuppressed patients with kidney disease and healthy donors.

Hyoung-Tae Jin1, Seok-Joo Park1, Eun-Kyoung Choi2, Yong-Sun Kim3.   

Abstract

Merkel cell polyomavirus (MCPyV) is a rare, aggressive and related to human diseases in immunocompromised patients. MCPyV has been detected in skin neoplasms, various cancers, immunosuppressed patients and immunocompetent individuals. Several studies have confirmed the presence of MCPyV in patients with kidney dysfunction, such as kidney transplant (KTx) and long-term dialysis patients. The aims of this study were to quantify and compare the frequency of MCPyV in whole blood samples from immunocompetent and immunosuppressed patients and healthy blood donors and to compare MCPyV genotypes in a Korean population. DNA from Groups 1, 2, and 3 was screened for MCPyV using polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) with primer pairs targeting two regions of the large T-antigen. Thirteen of 122 whole-blood samples (12.7%) were positive for MCPyV. The virus was detected in the three groups of patients and healthy donors; specifically, in 5 of 30 (16.7%) KTx patients (Group 1), 6 of 52 (11.5%) dialysis patients (Group 2), and 4 of 40 (10%) healthy donors (Group 3). Low viral DNA loads 4.4-18 copies/μl were observed using qPCR DNA sequences from the two MCPyV-LT regions, which showed high homology with MCPyV sequences belonging to the TKS strain from Japan rather than the Chinese/European/North American strains. The MCPyV DNA was similarly amplified in whole blood from immunocompetent and immunosuppressed patients and healthy donors. This virus may be involved in establishing the persistence of infected peripheral leukocytes in the host, based on the incidence of detection of MCPyV DNA in blood samples from immunocompromised and immunocompetent subjects. This study is the first to identify a Korean MCPyV strain in whole-blood samples from Korean patients with kidney disease and healthy individuals.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Healthy blood donors; Hemodialysis patient; Kidney transplant; Merkel cell polyomavirus; Peritoneal dialysis patient

Mesh:

Substances:

Year:  2019        PMID: 30910721     DOI: 10.1016/j.micpath.2019.03.020

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

Review 1.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

2.  Significantly Low Levels of IgG Antibodies Against Oncogenic Merkel Cell Polyomavirus in Sera From Females Affected by Spontaneous Abortion.

Authors:  Chiara Mazziotta; Giulia Pellielo; Mauro Tognon; Fernanda Martini; John Charles Rotondo
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

Review 3.  Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma.

Authors:  John Charles Rotondo; Chiara Mazziotta; Carmen Lanzillotti; Mauro Tognon; Fernanda Martini
Journal:  Int J Mol Sci       Date:  2021-10-24       Impact factor: 5.923

4.  Decreased IgG Antibody Response to Viral Protein Mimotopes of Oncogenic Merkel Cell Polyomavirus in Sera From Healthy Elderly Subjects.

Authors:  Chiara Mazziotta; Carmen Lanzillotti; Marcello Govoni; Giulia Pellielo; Elisa Mazzoni; Mauro Tognon; Fernanda Martini; John Charles Rotondo
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

Review 5.  The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma.

Authors:  Chiara Mazziotta; Carmen Lanzillotti; Roberta Gafà; Antoine Touzé; Marie-Alice Durand; Fernanda Martini; John Charles Rotondo
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.